These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 3429102

  • 1. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M.
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [Abstract] [Full Text] [Related]

  • 2. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC, Bonnot D, Berthod F, Boitard M, Reymond JL, Beriel H, Amblard P.
    Ann Dermatol Venereol; 1991 Dec; 118(4):273-5. PubMed ID: 2069337
    [Abstract] [Full Text] [Related]

  • 3. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P, Ortel B, Carlino A, Honigsmann H, De Panfilis G.
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [Abstract] [Full Text] [Related]

  • 4. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H, Jaschke E, Gschnait F, Brenner W, Fritsch P, Wolff K.
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [Abstract] [Full Text] [Related]

  • 5. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F, Makki S, Humbert P, Muret P, Agache P.
    Arch Dermatol Res; 1994 Oct; 286(1):30-4. PubMed ID: 8141609
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
    Pham CT, Koo JY.
    J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
    [Abstract] [Full Text] [Related]

  • 7. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema.
    De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W.
    Br J Dermatol; 1995 Jun; 132(6):964-9. PubMed ID: 7662576
    [Abstract] [Full Text] [Related]

  • 8. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M, Tegeder I, Ochsendorf FR, Zollner TM, Ludwig R, Kaufmann R, Podda M.
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [Abstract] [Full Text] [Related]

  • 9. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG, Zane C, Carlino A, De Panfilis G.
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
    Engin B, Oguz O.
    Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
    [Abstract] [Full Text] [Related]

  • 11. Bath-water delivery of 8-methoxypsoralen therapy for psoriasis.
    Collins P, Rogers S.
    Clin Exp Dermatol; 1991 May; 16(3):165-7. PubMed ID: 1934565
    [Abstract] [Full Text] [Related]

  • 12. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P, Leenutaphong V, Sudtim S.
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [Abstract] [Full Text] [Related]

  • 13. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P, Rogers S.
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [Abstract] [Full Text] [Related]

  • 14. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A, Pukkala E, Koulu L, Jansén CT, Karvonen J.
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE, Schregenberger N, Dummer R, Panizzon RG.
    Dermatology; 1998 May; 197(1):25-30. PubMed ID: 9693181
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis.
    Thirumoorthy T, Tham SN, Tan YC.
    J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270
    [No Abstract] [Full Text] [Related]

  • 17. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
    Hofer A, Fink-Puches R, Kerl H, Quehenberger F, Wolf P.
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
    Neild VS, Scott LV.
    Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
    [Abstract] [Full Text] [Related]

  • 19. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
    Väätäinen N, Hollmen A, Fräki JE.
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
    [Abstract] [Full Text] [Related]

  • 20. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M, Ros AM.
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.